Health is a precious possession. It requires ongoing attention and deserves the highest quality medicines to maintain it. At Nanomi, we are pushing the boundaries of medicine innovation with our cutting-edge PrecisionSphere™ technology that can be used in the development of high-quality, controlled, long-acting release therapies.
In addition to our own development program, we are interested in strategic partnerships with companies that will help bring more long-acting injectables to patients even faster.
Learn about our partnership optionsScroll
At the heart of Nanomi’s offerings lies our PrecisionSphere technology. This proprietary particle control technology is proven to deliver drugs effectively and safely, addressing critical compliance challenges that cost pharmaceutical companies millions in lost revenue and failed treatment outcomes. Unlike conventional long-acting injectable technologies that produce variable particle sizes, PrecisionSphere enables the production of medicines with uniform particle size, shape, and biological properties leading to improved injectability and optimized drug concentration release.
Read more about our technologyNanomi is a patient-centric driven company committed to making the best treatments, the best way, to transform the lives of patients and their families. Our mission is to develop and commercialize innovative long-acting injectables to improve health outcomes for patients around the world.
Learn about our valuesNanomi is a subsidiary of the Lupin group. Lupin is an innovation-led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients globally. The Company is a major player in the cardiovascular, diabetes, asthma, paediatrics, central nervous system, gastrointestinal, anti-infective and NSAID space and holds global leadership position in the anti-tuberculosis field.
Nanomi offers a workplace designed for ambitious and talented people who want to work in a dynamic, research-driven organization. With an international culture and a constant focus on innovation, our team is at the foreground of ground-breaking technologies and products.
Dit zal sluiten in 0 seconden
Dit zal sluiten in 0 seconden